Lantus, the new long-acting "peakless" insulin

Patients will soon be able to get Lantus, the new long-acting "peakless" insulin.

It was approved last year...but Aventis had to postpone the launch until they had an adequate supply.

Lantus is an insulin analog called insulin glargine. It differs from human insulin by 3 amino acids.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote